Literature DB >> 22203381

Vitiligo-like hypopigmentation and metastatic melanoma of unknown primary site: friends or foes?

Julio Cesar Salas-Alanis, Roger Gonzalez, Giulio Fortuna.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22203381     DOI： 10.1007/s12032-011-0146-z

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  7 in total

1.  Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre.

Authors:  Paola Savoia; Paolo Fava; Simona Osella-Abate; Tiziana Nardò; Alessandra Comessatti; Pietro Quaglino; Maria Grazia Bernengo
Journal:  Melanoma Res       Date:  2010-06       Impact factor: 3.599

2.  Vitiligo-like Depigmentation Associated with Metastatic Melanoma of an Unknown Origin.

Authors:  Eun Ah Cho; Myung Ah Lee; Hoon Kang; Seung Dong Lee; Hyung Ok Kim; Young Min Park
Journal:  Ann Dermatol       Date:  2009-05-31       Impact factor: 1.444

Review 3.  Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature.

Authors:  K Kamposioras; G Pentheroudakis; D Pectasides; N Pavlidis
Journal:  Crit Rev Oncol Hematol       Date:  2010-05-31       Impact factor: 6.312

4.  Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations.

Authors:  B Schlagenhauff; W Stroebel; U Ellwanger; F Meier; C Zimmermann; H Breuninger; G Rassner; C Garbe
Journal:  Cancer       Date:  1997-07-01       Impact factor: 6.860

5.  Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009.

Authors:  Anne F Pfeil; Ulrike Leiter; Petra G Buettner; Thomas K Eigentler; Benjamin Weide; Friedegund Meier; Claus Garbe
Journal:  Melanoma Res       Date:  2011-06       Impact factor: 3.599

6.  Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.

Authors:  P Quaglino; F Marenco; S Osella-Abate; N Cappello; M Ortoncelli; B Salomone; M T Fierro; P Savoia; M G Bernengo
Journal:  Ann Oncol       Date:  2009-07-21       Impact factor: 32.976

7.  Skin metastases of malignant melanoma: a clinical and prognostic survey.

Authors:  Paola Savoia; Paolo Fava; Tiziana Nardò; Simona Osella-Abate; Pietro Quaglino; Maria Grazia Bernengo
Journal:  Melanoma Res       Date:  2009-10       Impact factor: 3.599
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.